Company page

Chemocentryx Inc.

Chemocentryx Inc. (ticker: CCXI) is a public company based in the United States with a market capitalization of approximately $569 million. The company focuses on developing innovative therapies for autoimmune diseases and cancer. Chemocentryx aims to address unmet medical needs through its research and development efforts.